Pulse Biosciences, Inc. PLSE Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Pulse Biosciences, Inc. (PLSE) reported cash provided by (used in) operating activity, including discontinued operation of -$14.6M in Q1 2026.
- How has Pulse Biosciences, Inc.'s cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Pulse Biosciences, Inc.'s cash provided by (used in) operating activity, including discontinued operation decreased by 7.9% year-over-year, from -$13.52M to -$14.6M.
- What is the long-term trend for Pulse Biosciences, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s cash provided by (used in) operating activity, including discontinued operation has grown at a 0.0% compound annual growth rate (CAGR), from -$54.1M to -$54.12M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.